Earnings
Ironwood Shares Surge After Strong 2026 Guidance Outlook
Ironwood Pharmaceuticals shares jumped after the company issued 2026 guidance well above consensus, highlighting higher LINZESS sales, expanding profitability, and a strengthened balance sheet heading into the new year.